NOT, TARCISIO
 Distribuzione geografica
Continente #
NA - Nord America 15.862
EU - Europa 6.486
AS - Asia 2.401
SA - Sud America 43
Continente sconosciuto - Info sul continente non disponibili 39
AF - Africa 21
OC - Oceania 14
Totale 24.866
Nazione #
US - Stati Uniti d'America 15.833
UA - Ucraina 1.354
SE - Svezia 1.246
PL - Polonia 1.142
IT - Italia 996
CN - Cina 762
SG - Singapore 586
HK - Hong Kong 508
FI - Finlandia 435
TR - Turchia 411
DE - Germania 295
IE - Irlanda 234
BG - Bulgaria 220
GB - Regno Unito 217
FR - Francia 138
EU - Europa 36
IN - India 34
ES - Italia 33
BR - Brasile 29
BE - Belgio 28
CH - Svizzera 26
CA - Canada 25
KR - Corea 22
NL - Olanda 22
RU - Federazione Russa 22
VN - Vietnam 22
CZ - Repubblica Ceca 16
IR - Iran 16
RO - Romania 12
AU - Australia 11
PT - Portogallo 10
SN - Senegal 10
AT - Austria 9
DK - Danimarca 9
ID - Indonesia 7
JP - Giappone 7
CL - Cile 6
HR - Croazia 6
AR - Argentina 4
IL - Israele 4
IQ - Iraq 4
MX - Messico 4
MY - Malesia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BA - Bosnia-Erzegovina 3
DZ - Algeria 3
LV - Lettonia 3
MA - Marocco 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
AE - Emirati Arabi Uniti 2
EG - Egitto 2
HU - Ungheria 2
LK - Sri Lanka 2
SI - Slovenia 2
SZ - Regno dello Swaziland 2
TH - Thailandia 2
AM - Armenia 1
BD - Bangladesh 1
BO - Bolivia 1
BY - Bielorussia 1
CO - Colombia 1
CY - Cipro 1
EC - Ecuador 1
KZ - Kazakistan 1
MD - Moldavia 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
PK - Pakistan 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
VE - Venezuela 1
Totale 24.866
Città #
Woodbridge 2.131
Ann Arbor 1.847
Fairfield 1.786
Houston 1.665
Jacksonville 1.202
Warsaw 1.125
Chandler 987
Ashburn 983
Wilmington 877
Seattle 769
Cambridge 610
Hong Kong 495
Singapore 478
Princeton 448
Boardman 414
Izmir 380
Beijing 265
Dublin 234
Columbus 223
Sofia 220
Trieste 212
Dearborn 119
Milan 104
Düsseldorf 91
San Diego 88
Bremen 82
Verona 61
Santa Clara 57
Buffalo 47
Helsinki 41
Nanjing 36
Chicago 35
Des Moines 35
Sacile 35
Jinan 31
Brussels 27
Kunming 27
Falls Church 25
Munich 25
Guangzhou 23
Dong Ket 22
Fremont 22
Mestre 22
Hefei 21
Norwalk 21
Seoul 19
Bern 17
Pune 17
Rome 16
Brno 15
Redwood City 15
London 14
São Paulo 14
Toronto 14
Shenyang 13
Phoenix 12
Washington 12
Dallas 11
Gothenburg 11
Los Angeles 11
Dakar 10
Fuzhou 10
Hebei 10
San Francisco 10
Auburn Hills 9
Nanchang 9
Shanghai 9
Torre Del Greco 9
Bologna 8
New York 8
Port Coquitlam 8
Vienna 8
Chongqing 7
Detroit 7
Dongguan 7
Hangzhou 7
Mumbai 7
Palermo 7
Redmond 7
Taizhou 7
Tulsa 7
Zhengzhou 7
Andover 6
Ferrara 6
Grafing 6
Philadelphia 6
Seville 6
Tappahannock 6
Ankara 5
Chengdu 5
Madrid 5
Moscow 5
Perth 5
Scafati 5
Tokyo 5
Udine 5
Vicenza 5
Wuhan 5
Xian 5
Bari 4
Totale 18.932
Nome #
Ex vivo response to mucosal bacteria and muramyl dipeptide in inflammatory bowel disease 366
Interleukin-1β levels predict long-term mortality and need for heart transplantation in ambulatory patients affected by idiopathic dilated cardiomyopathy 318
Cross-sectional study of coeliac autoimmunity in a population of Vietnamese children 290
Combined Analysis of Methylation and Gene Expression Profiles in Separate Compartments of Small Bowel Mucosa Identified Celiac Disease Patients’ Signatures 283
Electrochemical Immunosensor Based on Nanoelectrode Ensembles for the Serological Analysis of IgG-type Tissue Transglutaminase 258
Ghrelin Derangements in Idiopathic Dilated Cardiomyopathy: Impact of Myocardial Disease Duration and Left Ventricular Ejection Fraction 249
Intestinal production of anti-tissue transglutaminase 2 antibodies in patients with diagnosis other than celiac disease 233
Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. 233
Testing for Anti-Human Transglutaminase Antibodies in Saliva Is Not Useful for Diagnosis of Celiac Disease 219
Changing Epidemiology of Liver Involvement in Children with Celiac Disease 219
Variant mannose-binding lectin alleles are associated with celiac disease 214
Looking for celiac disease: diagnostic accuracy of two rapid commercial assays 214
Galectin 3 and Galectin 3 Binding Protein Improve the Risk Stratification after Myocardial Infarction 208
Diagnostic accuracy and applicability of intestinal auto-antibodies in the wide clinical spectrum of coeliac disease 207
Anti-transglutaminase antibodies and age. 200
Autoantibodies as predictors of disease. 193
The Use of Biopsy and "no-Biopsy" Approach for Diagnosing Paediatric Coeliac Disease in the Central European Region 191
Diagnostic Delays in Children with Coeliac Disease in the Central European Region 187
Analyzing the peripheral blood antibody repertoire of a celiac disease patient using phage antibody libraries 186
Potential use of MCR-ALS for the identification of coeliac-related biochemical changes in hyperspectral Raman maps from pediatric intestinal biopsies 185
The gut as site of production of autoimmune antibodies. 184
Regulatory T-Cell Function Is Impaired in Celiac Disease. 184
Sedation with intranasal midazolam of Angolan children undergoing invasive procedures. 184
Anti transglutaminase antibodies cause ataxia in mice. 181
Tag-single nucleotide polymorphism-based human leukocyte antigen genotyping in celiac disease patients from northeastern Italy 180
Serum Anti-Tissue Transglutaminase Antibodies Detected during Febrile Illness May Not Be Produced by the Intestinal Mucosa 172
Anti-transglutaminase 6 antibody development in children with celiac disease correlates with duration of gluten exposure 171
One-step cloning of anti tissue transglutaminase scFv from subjects with celiac disease. 168
Coeliac disease in the ERA of the new ESPGHAN and BSPGHAN guidelines: a prospective cohort study 165
The humoral response in the pathogenesis of gluten ataxia 163
A reliable screening procedure for coeliac disease in clinical practice. 163
Gastrointestinal Foxp3 expression in normal, inflammatory and neoplastic conditions 158
Immunohistologic analysis of the duodenal bulb: a new method for celiac disease diagnosis in children 156
Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease. 156
Molecular dissection of the tissue transglutaminase auto-antibody response in celiac disease 155
Dual sugar gut-permeability testing on blood drop in animal models. 154
The analysis of the fine specificity of celiac disease antibodies using tissue transglutaminase fragments 153
Prevalence of celiac disease in patients with severe food allergy 149
Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease 146
Development of a novel rapid non-invasive screening test for coeliac disease. 146
Innate and adaptive immunity in self-reported nonceliac gluten sensitivity versus celiac disease 146
Natural isoprenoids are able to reduce inflammation in a mouse model of mevalonate kinase deficiency. 145
Sensitivity and specificity of simple and rapid commercial assays for the diagnosis of coeliac disease 144
null 143
Characterization of the anti-tissue transglutaminase antibody response in nonobese diabetic mice. 142
Strip AGA test: a rapid and accurate method in screening for coeliac disease 141
Association study of the IL18RAP locus in three European populations with coeliac disease 141
Cost-effective HLA typing with tagging SNPs predicts celiac disease risk haplotypes in the Finnish, Hungarian, and Italian populations 139
Speeding up coeliac disease diagnosis in cardiological settings 138
Evaluation of gut-vascular barrier by plasmalemma vesicle-associated protein-1 measurements in patients with celiac disease and abnormal serum alanine transaminase 138
The shared CTLA4-ICOS risk locus in celiac disease, IgA deficiency and common variable immunodeficiency 137
Digital Radiology to Improve the Quality of Care in Countries with Limited Resources: A Feasibility Study from Angola 136
Serological Proteome Analysis (SERPA) as a tool for the identification of new candidate autoantigens in type 1 diabetes. 136
A Functional Idiotype/Anti-Idiotype Network Is Active in Genetically Gluten-Intolerant Individuals Negative for Both Celiac Disease-Related Intestinal Damage and Serum Autoantibodies 135
A novel quantitative ELISA as accurate and reproducible tool to detect epidermal transglutaminase antibodies in patients with Dermatitis Herpetiformis 135
Ages of celiac disease: from changing environment to improved diagnostics 134
Anti-α-enolase Antibodies in Serum from Pediatric Patients Affected by Inflammatory Diseases: Diagnostic and Pathogenetic Insights. 134
Gluten dependent diabetes-related and thyroid-related autoantibodies in coeliac patients: a prospective study. 133
Zonulin is involved in the impairment of the gut barrier function following small intestinal bacterial colonization 132
Anti-idiotypic response in mice expressing human autoantibodies. 131
Role of zonulin in the intestinal permeability changes typical of the acute phase of coeliac disease 131
Alterations in zonulinsecretion precedes the onset of diabetes in BB/Wor rats 131
Humoral response in the pathogenesis of gluten ataxia 131
Mass screening for coeliac disease using antihuman transglutaminase antibody assay. 130
Celiac disease in patients with sporadic and inherited cardiomyopathies and in their relatives. 129
Screening ofcoeliac disease in helthy blood donors from two immunotransfusionalcenters in nothest Italy 129
Prevalence of celiac disease among risk groups and the general population in USA 129
Coeliac disease in primary care: evaluation of a case-finding strategy 127
Role of zonulin in the intestinal permeability changes typical of the acute phase of coeliac disease. 127
Compliance with the gluten-free diet: the role of locus of control in celiac disease 126
A population based seroepidemiological survey of Chlamydia pneumoniaeinfections in schoolchildren. 125
Anti-brain but not celiac disease antibodies in Landau-Kleffner Syndrome and related epilepsies. 124
Anti-transglutaminase antibodies in non-coeliac children suffering from infectious diseases 124
Cloning and characyerization of intestinal antibodies to tissue transglutaminase in celiac disease patients 123
Intestinal-mucosa anti-transglutaminase antibody assays to test for genetic gluten intolerance 123
The active Zot domain (aa 288–293) increases ZO-1 and myosin 1C serine/threonine phosphorylation, alters interaction between ZO-1 and its binding partners, and induces tight junction disassembly through proteinase activated receptor 2 activation 122
Validation of point-of-care testing for coeliac disease in children in a tertiary hospital in north India 122
The microsnapwell system: a new in vitro polarized model for studying the intestinal barrier functions using small intestinal biopsy specimens 120
Probiotics prevent zonulin-mediated intestinal barrier dysfunction secondary to bacterial colonization 119
Speeding up coeliac disease diagnosis in the developing countries 117
Anti-tissue transglutaminase antibodies from coeliac patients inhibit transglutaminase activity both in vitro and in situ. 116
Uselessness of anti-actin antibody in celiac disease screening 116
Human tissue transglutaminase ELISA: powerful massscreening diagnostic assay for coeliac disease 116
Rapid and simple dot immunobinding assay to detect anti human transglutaminase antibodies in coeliac disease 116
Leonardo da vinci meets celiac disease 116
null 114
null 114
Profiling celiac disease antibody repertoire 114
Autoinflammatory syndromes and coeliac disease: One observation and two hypotheses 113
Antibodies to transglutaminasefrom phage display libraries 112
IL23R in the Swedish, Finnish, Hungarian and Italian populations: association with IBD and psoriasis, and linkage to celiac disease. 111
Usefulness of gluten-free diet in gluten-genetically predisposed subjects positive to intestinal mucosa anti-transglutaminase antibodies 111
A new, rapid, noninvasive screening test for celiac disease. 110
Increasing titres of anti-human-transglutaminase antibodies with age in healthy population 110
Search for atoxic cereals: a single blind, cross-over study on the safety of a single dose of Triticum monococcum, in patients with celiac disease. 110
A Sensitive Electrochemiluminescence Immunosensor for Celiac Disease Diagnosis Based on Nanoelectrode Ensembles 110
Mucosal tissue transglutaminase expression in celiac disease 110
Protective role of anti-idiotypic network in celiac disease prone subjects 109
Human tissue transglutaminase ELISA and an old study: a revision of the blood donor screening study for coeliac disease in the USA. 107
Anti-transglutaminase and age, Clinical Chemestry 107
Totale 15.452
Categoria #
all - tutte 70.097
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.097


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.294 0 0 0 0 320 663 532 571 433 245 377 153
2020/20213.619 365 283 409 439 265 391 193 319 129 407 91 328
2021/20222.367 108 198 110 269 84 181 95 84 296 233 217 492
2022/20233.145 361 379 234 396 362 561 16 269 377 19 108 63
2023/20241.818 114 120 80 118 199 139 314 351 41 33 147 162
2024/20251.297 43 163 293 391 407 0 0 0 0 0 0 0
Totale 25.349